A selection of articles and news about quality metrics.
PDA works with FDA to create pharmaceutical quality metrics.
Industry players offer suggestions for quality metrics as FDA continues to try and solve the problem of drug shortages.
Regulators work with manufacturers to improve systems for measuring product performance and manufacturing reliability.
PDA Panel Proposes Limited Set of Metrics to Measure Quality Trends
PharmTech Talk
January 28, 2014
By: Jill Wechsler
Industry Needs to Drive the Dialogue Regarding FDA’s Quality Metrics Initiative
October 24, 2013 PharmTech Talk
Guest blog written by Walter Morris, Director of Publishing, Parenteral Drug Association, on behalf of the PDA Quality Metrics Task Force.
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.